Trastuzumab, sold under the brand Herceptin, is a monoclonal antibody used to treat patients suffering from HER2+ve breast cancer and gastric cancers.
Herceptin Biosimilar Market: Introduction
Trastuzumab, sold under the brand Herceptin, is a monoclonal antibody used to treat patients suffering from HER2+ve breast cancer and gastric cancers. It is primarily administered intravenously in cancer patients. Herceptin binds to HER2 receptors on the surface of breast cancer cells and blocks them from receiving growth signals, thereby leading to apoptosis and decrease in mutation of cells.
Read Report Overview - https://www.transparencymarketresearch.com/herceptin-biosimilar-market.html
Key Drivers and Restraints of Global Herceptin Biosimilar Market
- Breast cancer is one of the leading causes of death among women across the globe. Increase in incidence and prevalence of gastric & breast cancer among people, especially women, is a key factor boosting the growth of the global Herceptin biosimilar market. According to a report by the World Health Organization in 2019, nearly 627,000 women across the globe succumbed to breast cancer, which accounted for around 15% of all cancer deaths among women, in 2018.
- New product launches along with a number of products in pipeline for clinical trials, approval of new Herceptin biosimilar drugs by key companies, technological advancements, increase in health care expenditure, and considerable research & development activities drive the global Herceptin biosimilar market.
- However, lack of awareness among people about the treatment of gastric & breast cancer with Herceptin is likely to hamper the growth of the global Herceptin biosimilar market in the next few years
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=82800
Breast Cancer to Dominate Global Herceptin Biosimilar Market
- In terms of indication, the global Herceptin biosimilar market can be classified into breast cancer, gastric cancer, and others
- The breast cancer segment is projected to dominate the global Herceptin biosimilar market during the forecast period due to increase in incidence and prevalence rate of breast cancer among women
Request for Analysis of COVID-19 Impact on Herceptin Biosimilar Market- https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=82800
Hospital Pharmacy Segment to Capture Largest Market Share
- Based on distribution channel, the global Herceptin biosimilar market can be divided into hospital pharmacies, retail pharmacies, online pharmacies, oncology centers, and others
- The hospital pharmacies segment is anticipated to capture the largest market share due to rise in the number of patients admitted to hospitals & clinics for treatment and health care infrastructure provided by hospitals such as intensive care units (ICU) and ventilators.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=82800
North America to Lead Global Herceptin Biosimilar Market
- In terms of region, the global Herceptin biosimilar market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- North America accounted for the largest market of the global Herceptin biosimilar market in 2020, followed by Europe. Increase in number of people suffering from gastric & breast cancer, technological advancements, rise in government grants & funding, and presence of large number of key players boost the growth of the market in North America.
Pre Book Herceptin Biosimilar Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=82800<ype=S
Key Manufacturers Operating in Global Herceptin Biosimilar Market
The global Herceptin biosimilar market was highly fragmented in 2020.
More Trending Reports by Transparency Market Research:
Anti-Cathepsin B Market
https://www.transparencymarketresearch.com/anticathepsin-b-market.html
Progressive Familial Intrahepatic Cholestasis Type 2 Treatment Market https://www.transparencymarketresearch.com/progressive-familial-intrahepatic-cholestasis-type-2-treatment-market.html
Advanced Glycation End Products Market
https://www.transparencymarketresearch.com/advanced-glycation-end-products-market.html
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/